Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone in Major Depressive Disorder With Psychotic Features
NCT00174590Phase 3Terminated
- Sponsor
- Rush University Medical Center
- Start
- Sep 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of risperidone (3 arms), sponsored by Rush University Medical Center. Primary endpoint: Hamilton Depression Rating Scale. Started Sep 2001; status: terminated.
02
Drugs
risperidone
Beyond the preview
Go deeper on NCT00174590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00174590.